Education
About Us
Working with TipRanks
Follow Us
Parkway Corporate Limited (DE:4IP)
FRANKFURT:4IP
4IP Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Manageable Leverage And Stable Capital StructureA moderate debt-to-equity (0.47) and a high equity ratio (60.27%) indicate a stable capital base and manageable leverage. This reduces near-term refinancing risk, preserves borrowing capacity for expansion or capex, and supports resilience across a 2–6 month horizon.
Consistent Revenue GrowthSustained top-line growth (~6% year) points to steady demand for healthcare services and incremental market penetration. Ongoing revenue expansion provides a base to scale operations, absorb fixed costs, and potentially improve margins over several months if cost control holds.
Diversified Healthcare Services ModelA business mix of inpatient, outpatient and diagnostic services creates multiple, recurring revenue streams and cross-referral opportunities. This structural diversification reduces reliance on any single service line and supports more stable cash flows over the medium term.
Bears Say
Very Low Profitability MarginsExtremely thin gross and net margins signal limited pricing power or elevated operating costs. Low profitability constrains retained earnings and the ability to reinvest, leaving little buffer against cost inflation and hindering sustainable improvement in shareholder returns over months.
Sharply Declining Free Cash Flow And Weak Cash ConversionA steep ~57% FCF decline and weak cash conversion ratios indicate operations are not turning earnings into cash. This limits liquidity for capex, debt service, or strategic investments, increasing financial rigidity and raising execution risk over the medium term.
Inefficient Returns On EquityNear-zero ROE reflects poor effectiveness in using shareholder capital, likely driven by low margins or underutilized assets. Persistently low returns make it difficult to attract capital and suggest structural operational inefficiencies that impede long-term value creation.
Parkway Corporate Limited News
4IP FAQ
What was Parkway Corporate Limited’s price range in the past 12 months?
Currently, no data Available
What is Parkway Corporate Limited’s market cap?
Parkway Corporate Limited’s market cap is €18.45M.
When is Parkway Corporate Limited’s upcoming earnings report date?
Parkway Corporate Limited’s upcoming earnings report date is Sep 24, 2026 which is in 203 days.
How were Parkway Corporate Limited’s earnings last quarter?
Parkway Corporate Limited released its earnings results on Feb 27, 2026. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Parkway Corporate Limited overvalued?
According to Wall Street analysts Parkway Corporate Limited’s price is currently Undervalued.
Does Parkway Corporate Limited pay dividends?
Parkway Corporate Limited does not currently pay dividends.
What is Parkway Corporate Limited’s EPS estimate?
Parkway Corporate Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parkway Corporate Limited have?
Parkway Corporate Limited has 2,768,910,600 shares outstanding.
What happened to Parkway Corporate Limited’s price movement after its last earnings report?
Parkway Corporate Limited reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Parkway Corporate Limited?
Currently, no hedge funds are holding shares in DE:4IP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Parkway Corporate Limited
Parkway Corporate Limited, a cleantech company, provides water treatment solutions in Australia. It operates through three business units: Parkway Process Solutions, Parkway Process Technologies, and Parkway Ventures. The company offers analytical instruments for measuring water treatment related parameters; laboratory equipment; laboratory consumables, such as syringes, test tubes, measuring jugs, cylinders, and flasks; water treatment systems; and a range of pumps comprising specialty chemical dosing pumps, HVAC pumps, submersible pumps, and high-pressure and high-capacity pumps, as well as related parts and accessories. It also provides instrumentation and controllers to measure, monitor, and automate water treatment operations; pipe, hose, and fittings products; valves and solenoids; filters, membranes, and related process equipment; and a range of tanks for high-value industrial water treatment and process related applications. In addition, the company offers various water treatment chemicals; and disinfection products that consist of chemical disinfection, chlorination equipment, ozone disinfection, and UV disinfection products, as well as related parts and accessories. Further, it provides analytical testing, project evaluation, process development, project engineering, installation and project management, and operation and maintenance services. Additionally, the company holds interest in the Karinga Lakes potash project located in the northern territory of Australia; and owns a portfolio of industrial wastewater treatment technologies. The company was formerly known as Parkway Minerals NL and changed its name to Parkway Corporate Limited in September 2021. The company was incorporated in 2010 and is based in Sunshine North, Australia.
Agrimin Limited
―
American West Metals Ltd.
―
WA Kaolin Ltd.
―
Arizona Lithium Limited
―
Richmond Vanadium Technology Pty Ltd.
―